-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Relmada Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2013 to Q1 2024.
- Relmada Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $10.1M, a 74.9% decline year-over-year.
- Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $50.5M, a 156% increase from 2022.
- Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $19.7M.
- Relmada Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$54.1M, a 57.1% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)